Allergy Therapeutics appoints David Ball to its Board as Independent Director
– UK, Worthing – Allergy Therapeutics (LON: AGY), the fully integrated commercial biotechnology company specializing in allergy vaccines, today announced the appointment of David Ball to its Board as an independent Non-Executive Director with immediate effect.…